Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - AVADEL PHARMACEUTICALS PLC | avadelcorporatepresentat.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 8-K
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2016
___________________
AVADEL PHARMACEUTICALS PLC
(Exact name of registrant as specified in its charter)
___________________
Ireland (State or Other Jurisdiction of Incorporation) | 000-28508 (Commission File Number) | Applied For (I.R.S. Employer Identification No.) | ||||
Block 10-1, Blanchardstown Corporate Park, Ballycoolin Dublin 15, Ireland (Address of Principal Executive Offices) | Not Applicable (Zip Code) | |||||
Registrant’s telephone number, including area code: +353 1 485 1200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
28866715
Item 7.01 Other Events.
On January 9, 2017, Avadel Pharmaceuticals plc posted an updated corporate presentation to the Events and Presentations section of its investors website. A copy of the Company’s complete slide presentation to is being furnished as Exhibit 99.1 to this Current Report on Form 8- K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 | Avadel Pharmaceuticals plc Corporate Presentation dated as of January 9, 2017. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Avadel Pharmaceuticals plc
By: /s/ Phillandas T. Thompson
Phillandas T. Thompson
Senior Vice President, General Counsel and Corporate Secretary
Date: January 11, 2017
Exhibit Index
99.1 | Avadel Pharmaceuticals plc Corporate Presentation dated as of January 9, 2017. | |
2
28866715